Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: lunt m. Arthritis Rheum. 2006 Aug;54(8):2368-76. doi: 10.1002/art.21978. Arthritis Rheum. 2006. PMID: 16868999 Free article.
Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.
Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Among authors: lunt m. Arthritis Rheum. 2007 Jan;56(1):13-20. doi: 10.1002/art.22331. Arthritis Rheum. 2007. PMID: 17195186 Free article.
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: lunt m. Arthritis Rheum. 2007 Sep;56(9):2905-12. doi: 10.1002/art.22809. Arthritis Rheum. 2007. PMID: 17763428 Free PMC article.
Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.
Dixon WG, Symmons DP, Lunt M, Watson KD, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: lunt m. Arthritis Rheum. 2007 Sep;56(9):2896-904. doi: 10.1002/art.22808. Arthritis Rheum. 2007. PMID: 17763441 Free PMC article.
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
Potter C, Hyrich KL, Tracey A, Lunt M, Plant D, Symmons DP, Thomson W, Worthington J, Emery P, Morgan AW, Wilson AG, Isaacs J, Barton A; BRAGGSS. Potter C, et al. Among authors: lunt m. Ann Rheum Dis. 2009 Jan;68(1):69-74. doi: 10.1136/ard.2007.084715. Epub 2008 Mar 28. Ann Rheum Dis. 2009. PMID: 18375541 Free PMC article.
Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study.
Adib N, Hyrich K, Thornton J, Lunt M, Davidson J, Gardner-Medwin J, Foster H, Baildam E, Wedderburn L, Thomson W. Adib N, et al. Among authors: lunt m. Rheumatology (Oxford). 2008 Jul;47(7):991-5. doi: 10.1093/rheumatology/ken085. Epub 2008 Apr 16. Rheumatology (Oxford). 2008. PMID: 18417527 Free PMC article.
Different methods of balancing covariates leading to different effect estimates in the presence of effect modification.
Lunt M, Solomon D, Rothman K, Glynn R, Hyrich K, Symmons DP, Stürmer T; British Society for Rheumatology Biologics Register; British Society for Rheumatology Biologics Register Control Centre Consortium. Lunt M, et al. Am J Epidemiol. 2009 Apr 1;169(7):909-17. doi: 10.1093/aje/kwn391. Epub 2009 Jan 19. Am J Epidemiol. 2009. PMID: 19153216 Free PMC article.
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.
Hyrich KL, Deighton C, Watson KD; BSRBR Control Centre Consortium; Symmons DP, Lunt M; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Among authors: lunt m. Rheumatology (Oxford). 2009 Oct;48(10):1323-7. doi: 10.1093/rheumatology/kep242. Epub 2009 Aug 25. Rheumatology (Oxford). 2009. PMID: 19706737 Free PMC article. Clinical Trial.
381 results